Dynamics of antibody titers to SARS-CoV-2 and clinical outcomes after sotrovimab pre-exposure prophylaxis early after allogeneic hematopoietic stem cell transplantation - Poll - MDSpire

Dynamics of antibody titers to SARS-CoV-2 and clinical outcomes after sotrovimab pre-exposure prophylaxis early after allogeneic hematopoietic stem cell transplantation

  • By

  • Gioele Capoferri

  • Carla Simone Walti

  • Pascal Urwyler

  • Silvio Ragozzino

  • Jakob R. Passweg

  • Jörg Halter

  • Manuel Battegay

  • Veronika Baettig

  • Maja Weisser

  • Brice Arnold

  • Benedict Morin

  • Yukino Guetlin

  • Diana Albertos Torres

  • Güliz Tuba Barut

  • Volker Thiel

  • Adrian Egli

  • Beatrice Drexler

  • Nina Khanna

  • February 16, 2023

  • 0 min

Share

Original Source(s)

Dynamics of antibody titers to SARS-CoV-2 and clinical outcomes after sotrovimab pre-exposure prophylaxis early after allogeneic hematopoietic stem cell transplantation

  • by Gioele Capoferri, Carla Simone Walti, Pascal Urwyler, Silvio Ragozzino, Jakob R. Passweg, Jörg Halter, Manuel Battegay, Veronika Baettig, Maja Weisser, Brice Arnold, Benedict Morin, Yukino Guetlin, Diana Albertos Torres, Güliz Tuba Barut, Volker Thiel, Adrian Egli, Beatrice Drexler, Nina Khanna

  • February 16, 2023

Related Content

Long-term Sequelae Following Dengue Infection vs SARS-CoV-2 Infection in a Pediatric Population: A Retrospective Cohort Study

Risk factors for a severe disease course in children with SARS-COV-2 infection following hematopoietic cell transplantation in the pre-Omicron period: a prospective multinational Infectious Disease Working Party from the European Society for Blood and Marrow Transplantation group (EBMT) and the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH) study

Acute liver failure and secondary TMA-like phenomenon following SARS-CoV-2 and Mycoplasma pneumoniae co-detection in a child: a case report